For the past 20 to 25 years, data has shown that half of patients prescribed long-term medications do not take them as prescribed.
Experts in dermatology review the dosing and meal requirements need with isotretinoin administration, highlighting the impact and benefit of the novel lidose and micronized formulations.
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.
A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.
Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.
Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Investigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.
A real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.
Pulsed dye lasers are now being used for several different dermatologic conditions.
There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Granulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.
Breakthroughs and approvals we can expect in the coming year.
In this upcoming video program, Lauren Miller, PA-C will lead a conversation about the management of plaque psoriasis; focusing on data relating to emerging efficacy and safety outcomes highlighting key disease clearance endpoints related to the practical and clinical considerations of this condition.
What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
Tirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.
There are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.
More research is needed to understand the pathogenesis underlying this association.
Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Payers must make public the individual amounts their health plans pay providers across all types of services and locations, including hospitals, doctors’ offices, imaging centers, outpatient surgery centers and urgent care clinics.